All Stories

  1. Primary care rheumatology: towards sustainable development in health
  2. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
  3. 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis
  4. Burden of osteoarthritis in India and its states, 1990–2019: findings from the Global Burden of disease study 2019
  5. Common mental disorders in South Asian patients with systemic sclerosis: a CIS-R-based cross-sectional study
  6. Biologics in Takayasu’s Arteritis
  7. Salivary free light chains and salivary immunoglobulins as potential non‐invasive biomarkers in primary Sjögren's syndrome
  8. Online academic community in the Asia‐Pacific countries: The paragon of a metamorphic world
  9. Magnetic Resonance Imaging evidence of Inflammation at Interphalangeal joint of Thumb — A distinct entity in psoriatic arthritis
  10. Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome
  11. Update on pregnancy in Takayasu arteritis—A narrative review
  12. In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome
  13. Cotrimoxazole prophylaxis prevents major infective episodes in patients with systemic lupus erythematosus on immunosuppressants: A non-concurrent cohort study
  14. Update on Post-Streptococcal Reactive Arthritis: Narrative Review of a Forgotten Disease
  15. High expression of pro-inflammatory cytokine genes IL-1β and IL-1R2 upon TLR4 activation in Takayasu arteritis
  16. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management
  17. Understanding immunopathological fallout of human coronavirus infections including COVID‐19: Will they cross the path of rheumatologists?
  18. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
  19. Obstetric and perinatal outcomes in pregnant women with Takayasu’s arteritis: single centre experience over five years
  20. Diagnostic performance of dry eye tests, serology and labial salivary gland biopsy in primary Sjogren's syndrome in an Indian setting
  21. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials
  22. Authors' response
  23. The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis
  24. Recent advances in the management of Takayasu arteritis
  25. Vasculitis special issue
  26. A descriptive pilot study of mitochondrial mutations & clinical phenotype in fibromyalgia syndrome
  27. Letters from the outgoing and incoming Editor in Chief
  28. Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS
  29. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity
  30. Sjögren’s, Renal Tubular Acidosis and Osteomalacia - An Asian Indian Series
  31. Podocyte Infolding Glomerulopathy (PIG) in a Patient With Undifferentiated Connective Tissue Disease: A Case Report
  32. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India
  33. High Secretion of Interleukin-6 and Increased MINCLE Receptor Expression Upon Exposure to Mycobacterial Cord Factor Analog Trehalose-6, 6-Dibehenate (TDB) in Patients with Takayasu Arteritis
  34. PAI1 mediates fibroblast–mast cell interactions in skin fibrosis
  35. Carbon dioxide Angiography-Guided Renal-Related Interventions in Patients with Takayasu Arteritis and Renal Insufficiency
  36. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren’s syndrome
  37. Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study
  38. Clinical Predictors of Outcome in Buerger’s Disease using BVAS and DEI.Tak Scoring Systems
  39. Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis
  40. Study of serial serum myeloid-related protein 8/14 as a sensitive biomarker in Takayasu arteritis: a single centre study
  41. Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?
  42. Utility of CT imaging in differentiating sacroiliitis associated with spondyloarthritis from gouty sacroiliitis: a retrospective study
  43. C-reactive protein gene polymorphisms (rs1205) in Asian Indian patients with Takayasu arteritis: Associations and phenotype correlations
  44. Primary Sjögren's syndrome in Asia: Yin and Yang?
  45. Design and evaluation of cryodevice, an easy to use apparatus for maintenance of optimum temperature during cryoglobulin assay
  46. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis
  47. Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India
  48. Interleukin-17F and interleukin-6 gene polymorphisms in Asian Indian patients with Takayasu arteritis
  49. Utility of Plain Radiographs in Metabolic Bone Disease – A Case-Based Pictorial Review from a Tertiary Centre
  50. TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis
  51. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India
  52. Soluble-HLA-E: A follow up biomarker in Takayasu arteritis, independent of HLA-E genotype
  53. 403 Study of familial aggregation of autoimmune diseases in asian indian lupus patients (PROBANDS)
  54. Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity
  55. Egyptian tale from India: application of whole-exome sequencing in diagnosis of atypical familial Mediterranean fever
  56. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu's arteritis
  57. Chikungunya Infection: a Global Public Health Menace
  58. Update on Pathogenesis of Sjogren's Syndrome
  59. Pulmonary hypertension in connective tissue diseases: an update
  60. Vitamin D Levels and Associations in Indian Patients with Primary Sjögren’s Syndrome
  61. Anti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus
  62. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study
  63. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium
  64. High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren’s syndrome
  65. Psoriatic arthritis: lessons from imaging studies and implications for therapy
  66. Inflammation, metabolism and adipokines: toward a unified theory
  67. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
  68. MRI and ultrasound in rheumatoid arthritis
  69. ‘Outside the box’ genes, transcriptions and translations in Rheumatoid arthritis
  70. Younger patients with primary Sjögren’s syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies
  71. Gut inflammation and microbiome in spondyloarthritis
  72. Audiological Profile in Primary Sjögren’s Syndrome in a Tertiary Care Setting and its Clinical Implications
  73. Imaging in Takayasu arteritis
  74. Childhood-onset Takayasu arteritis: an update
  75. Proteomics in rheumatology
  76. The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis
  77. Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis
  78. Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lprmice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment
  79. Reliability of Test for Manual dexterity in arthritis
  80. Therapeutic potential of curcumin and curcumin analogues in rheumatology
  81. Clinical Characteristics and Outcome of Primary Sjogren’s Syndrome: A Large Asian Indian Cohort
  82. Does low bone density influence symptoms and functional status in patients with fibromyalgia? Observations from rural South India
  83. Haematological manifestations of lupus
  84. Lessons from Asian lupus
  85. Which is worse in psoriasis - skin or joints?
  86. Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population ?
  87. Fingerprint Deposition on Nitrocellulose and Polyvinylidene Difluoride Membranes Using Alkaline Phosphatase
  88. SDS-PAGE to Immunoblot in One Hour
  89. Takayasu's Arteritis
  90. Sjögren’s, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series
  91. Cytokine gene polymorphisms in Asian Indian patients with Takayasu’s Arteritis (TA) – a single center study
  92. Office e-MRI: viewing joints from the inside
  93. Malignancy and autoimmunity: causally or casually related?
  94. Want to become an author, a reviewer or an editor? The choice is yours
  95. Cost of publication - Who pays for it?
  96. Childhood-onset Takayasu Arteritis — Experience from a Tertiary Care Center in South India
  97. Morphological analysis of peripheral arterial signals in Takayasu’s arteritis
  98. Genetics of juvenile idiopathic arthritis
  99. Special interest groups for ‘sustainable rheumatology’
  100. Role of vacuolar ATPase and Skp1 in Sjögren’s syndrome
  101. Conflict of interest, an unspoken reality in science
  102. ‘Bamboo spine’, a thing of the past?
  103. ‘Treat to target’ for rheumatoid arthritis in 2014 - time tested triple therapy or logical Biologics?
  104. Collaboration, the other name for research
  105. New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity
  106. Next generation evidence-based medicine: individualised, personalised and humanised
  107. Rapid control of disease activity by tocilizumab in 10 ‘difficult-to-treat’ cases of Takayasu arteritis
  108. Expression of iron-related proteins in the duodenum is up-regulated in patients with chronic inflammatory disorders
  109. Juvenile dermatomyositis management: moving but in need of a push
  110. Promptness? - Yes, Haste? - No
  111. Infliximab and occult Hepatitis B infection: to treat or not to treat?
  112. Rare Retinal Manifestations in Takayasu Arteritis
  113. A descriptive analysis of 14 cases of progressive-psuedorheumatoid-arthropathy of childhood from south India: Review of literature in comparison with Juvenile Idiopathic Arthritis
  114. Fibromyalgia or pseudo fibromyalgia? - We have to get it right
  115. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)
  116. A secosteroid and not just a food for thought
  117. It bites the heart or does it not?
  118. How safe is Celecoxib for Asian-Indian patients with rheumatic diseases?
  119. REGRESSION OF TAKAYASU RETINOPATHY AFTER REVASCULARIZATION OF OCCLUDED BRANCHES OF THE AORTIC ARCH BY PERCUTANEOUS ANGIOPLASTY
  120. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study
  121. Analysis of the WISP3 gene in Indian families with progressive pseudorheumatoid dysplasia
  122. Vasculitis assessment and Takayasu aorto-arteritis
  123. Pancreatitis in Systemic Lupus Erythematosus - Case Series from a Tertiary Care Center in South India
  124. Paraneoplastic Palmar Fasciitis in Carcinoma Breast
  125. Clinico-pathological correlation of non specific inflammation in bowel histology with joint manifestation in a tertiary center in South India
  126. Eosinophilic Esophagitis and Pharyngitis Presenting as Mass Lesion in a Patient With Inactive Rheumatoid Arthritis
  127. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus
  128. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial
  129. Superior mesenteric artery syndrome in an adult rheumatoid arthritis patient
  130. OCULAR MANIFESTATIONS OF TAKAYASU ARTERITIS
  131. Pneumorrhachis and pneumomediastinum in connective tissue disease-related interstitial lung disease: case series from a tertiary care teaching hospital in South India
  132. Outcome of patients with seronegative spondyloarthritis continuing sulphasalazine and methotrexate after a short course of infliximab therapy—experience from a tertiary care teaching hospital in South India
  133. Primary Sjögren’s Syndrome: Report from India
  134. Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis
  135. Parkinsonism Mimicking Rheumatoid Arthritis
  136. Immune responses to Epstein-Barr virus in individuals with systemic and organ specific autoimmune disorders
  137. Mycophenolate mofetil in Takayasu’s arteritis
  138. Infection and Systemic Autoimmune Rheumatic Diseases
  139. Rheumatic Diseases and the Eye
  140. Acute pancreatitis as the initial presentation in pediatric systemic lupus erythematosus
  141. Osteoporosis in ankylosing spondylitis
  142. Relapsing polychondritis—case series from South India
  143. Rare presentation of Takayasu's aortoarteritis after double valve replacement
  144. Wegener’s granulomatosis—a rare presentation
  145. High frequency ultrasonography of the Achille's tendon in the diagnosis of enthesopathy in patients with spondyloarthropathy
  146. Correlation between serum methotrexate concentrations and disease remission status in rheumatoid arthritis patients on triple disease-modifying antirheumatic drug therapy
  147. Management of patients with fibromyalgia using biofeedback: A randomized control trial
  148. Update on Antiphospholipid Syndrome (APS)
  149. Dowling-Degos disease, hidradenitis suppurativa and arthritis in mother and daughter
  150. Management of Kikuchi Disease Using Glucocorticoids
  151. A case of Sjogren syndrome presented as interstitial pneumonia
  152. Absence of Antibody to HTLV-1 in Sera of Asian Indian Patients with Systemic Autoimmune Rheumatic Diseases
  153. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome
  154. Drug Resistant Tuberculosis in Diabetes Mellitus: A Retrospective Study from South India
  155. Lipodystrophy and connective tissue panniculitis
  156. Polymyositis - an unusual manifestation of chronic graft-versus-host disease
  157. EFFECT OF DIABETES MELLITUS ON SALIVARY PARACETAMOL ELIMINATION